Skip to content
AnalystLens
Back to MRNABalance Sheet

Moderna, Inc. Intangible Assets 2022-2026 | MRNA

Annual FY2022–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$45.0M

+12.5%YoY vs FY2024Source: 10-KFY2025

From $0 in FY2022 to $45.0M in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$116M+136.7%Not reportedNot reportedNot reported
FY25$49M+14.0%$48M+14.3%$47M+14.6%$45M+12.5%
FY24$43M−10.4%$42M−8.7%$41M−8.9%$40M−9.1%
FY23$48M$46M$45M$44M
FY22Not reportedNot reportedNot reported$0

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

N/A

FY2022
$0
FY2025
$45.0M

3 years selected · on the chart

01—History

Intangible Assets History

Year-over-year comparison from 10-K annual reports

  4. $45.0M
YoY changeLargest recent move−9.1%in FY24Latest +12.5%

02—Ledger

Intangible Assets, period by period

PeriodValueChangeSource
FY2025$45.0M+12.5%10-K
FY2024$40.0M−9.1%10-K
FY2023$44.0M—10-K
FY2022$0—10-K

03—Questions

What is intangible assets?

Intangible assets include non-physical assets such as patents, trademarks, copyrights, and customer relationships.

What is Moderna, Inc.'s current intangible assets?

Moderna, Inc. (MRNA) annual intangible assets for 2025 was $45.0M, a 12.50% increase from 2024. Moderna, Inc. intangible assets for the quarter ending March 31, 2026 was $116.0M.

What was Moderna, Inc.'s intangible assets in 2024?

Moderna, Inc. annual intangible assets for 2024 was $40.0M, a 9.09% decline from 2023.

What was Moderna, Inc.'s intangible assets in 2023?

Moderna, Inc. annual intangible assets for 2023 was $44.0M, a Infinity% increase from 2022.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
View company profile →